Effect of the anti-motion-sickness medication cinnarizine on central nervous system oxygen toxicity

Undersea and Hyperbaric Medicine

Volumn 26, Issue 2, 1999, Pages 105-109

  Arieli, R ^a   Shupak, A ^a   Shachal, B ^a   Shenedrey, A ^a   Ertracht, O ^a   Rashkovan, G ^a  

^a ISRAEL NAVAL MEDICAL INSTITUTE   (Israel)

Author keywords

Diving; Hyperbaric oxygen; Hyperoxia; Seizure

Indexed keywords

ANTIEMETIC AGENT; CINNARIZINE; HISTAMINE H1 RECEPTOR ANTAGONIST; OXYGEN;

ANIMAL; ARTICLE; BRAIN; DIVING; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; FOOD DEPRIVATION; MALE; MOTION SICKNESS; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIEMETICS; BRAIN; CINNARIZINE; DIVING; ELECTROENCEPHALOGRAPHY; FOOD DEPRIVATION; HISTAMINE H1 ANTAGONISTS; MALE; MOTION SICKNESS; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033143709     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Doweck I, Gordon CR, Spitzer O, Melamed Y, Shupak A. Effect of cinnarizine in the prevention of seasickness. Aviat Space Environ Med 1994; 65:606-609.
2. Shupak A, Doweck I, Gordon CR, Spitzer O. Cinnarizine in the prophylaxis of seasickness: laboratory vestibular evaluation and sea study. Clin Pharmacol Ther 1994; 55:670-680.
3. Kariya S, Isozaki S, Masubuchi Y, Suzuki T, Narimatsu S. Possible pharmacokinetic and pharmacodynamic factors affecting Parkinsonism inducement by cinnarizine and flunarizine. Biochem Pharmacol 1995; 50:1645-1650.
4. Godfraind T, Towse G, Van Nueten JM. Cinnarizine - A selective calcium entry blocker. Drugs Today 1982; 18:27-42.
5. Gersh I, Davies PW, Larrabee MG. 'Oxygen tension' of the central cortex of cats during oxygen poisoning. Project X-192, rep no. 6. Bethesda, MD: Naval Medical Research Institute, National Naval Medical Research Center, 1945.
6. Harel D, Kerem D, Lavy S. The influence of high oxygen pressure on the electrical activity of the brain. Electroencephalogr Clin Neurophysiol 1969; 26:310-317.
7. 2 toxicity in the rat. Eur J Appl Physiol 1997; 75: 182-187.
8. Arieli R, Hershko G. Prediction of central nervous system oxygen toxicity in rats. J Appl Physiol 1994; 77:1903-1906.
9. Bleiberg B, Kerem D. Central nervous system oxygen toxicity in the resting rat: postponement by intermittent oxygen exposure. Undersea Biomed Res 1988; 15:337-352.
10. 2. Eur J Appl Physiol 1998; 78:454-459.
11. 2 (abstract). Israel Physiological Society, Maale Hahamisha, 1997.
12. Bitterman N, Skapa E, Gutterman A. Starvation and dehydration attenuate CNS oxygen toxicity in rats. Brain Res 1997; 761:146-150.
13. Bitterman N, Eilender E, Melamed Y. Hyperbaric oxygen and scopolamine. Undersea Biomed. Res 1991; 18:167-174.
14. Lin Y, Jamieson D. Effect of humidity on hyperoxic toxicity. J Appl Physiol 1993; 75:1980-1983.
15. Stahl WR. Scaling of respiratory variables in mammals. J Appl Physiol 1967; 22:453-460.
16. Katz A, Kerem D. Sherman D. Magnesium sulfate suppresses electroencephalographic manifestations of CNS oxygen toxicity. Undersea Biomed Res 1990; 17:45-49.
17. Ben Bassat I, Bitterman N. The effect of flunarizine on central nervous system oxygen toxicity in rats. Eur J Pharmacol 1993; 228:241-246.
18. Colton CA, Colton JS. Blockade of hyperbaric oxygen induced seizures by excitatory amino acid antagonists. Can J Physiol Pharmacol 1985; 63:519-521.
19. Malis CD, Bonventr JV. Mechanism of calcium potentiation of oxygen free radical injury to renal mitochondria. A model for post-ischemic and toxic mitochondrial damage. J Biol Chem 1986; 261:14201-14208.
20. Flink EB, Dedhia HV, Dinsmore J, Doshi H M, Banks D, Hshieh P. High-dose magnesium sulfate attenuates pulmonary oxygen toxicity. Crit Care Med 1992; 20:1692-1698.